Arkolith/Insider Trading/KRON/Form 4

Bischofberger Norbert W

PRESIDENT & CEO, DirectorKronos Bio, Inc. (KRON) · full profile →Form 4 · filed Feb 16, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 15, 2024Grant(A)270K—$02.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2024Grant(A)700K—$0700K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-004262) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML